ASCs are entering 2026 with strong procedural demand and expanding clinical capabilities, but the financial picture is becoming far more complex.
Rising labor and supply costs, tightening reimbursement and increasingly aggressive payer behavior are compressing margins across the outpatient landscape. Leaders say the challenge is no longer just capturing growth, but sustaining profitability in an environment where costs are rising faster than revenue.
As a result, ASC operators are shifting their focus from expansion to execution, rethinking how they manage supply chains, structure partnerships, deploy capital and optimize operations.
Supply chain discipline becomes a frontline margin strategy
One of the most immediate areas of focus is supply chain discipline. Leaders are scrutinizing case-level costs, standardizing implants and reducing unnecessary variation in the operating room.
Even small inefficiencies, such as unused supplies or inconsistent physician preferences, can quickly erode margins at scale. Improving supply utilization and preference card accuracy are among the most actionable levers for controlling costs.
Capital strategy shifts from expansion to reinvestment
At the same time, many organizations are rethinking how they deploy capital. Rather than prioritizing facility expansion, more ASCs are shifting toward reinvestment in existing operations, technology and infrastructure.
According to a VMG Health report, 31% of leaders say capital procurement will be a major strategic focus in 2026, up from 20% the year prior, while the share planning facility expansion fell from 26% to 20%. The shift signals a move toward more disciplined investment strategies aimed at improving efficiency and protecting margins.
Partnerships emerge as a path to scale and stability
Partnership strategy is also evolving as more independent ASCs weigh alignment to navigate financial and operational pressures. According to VMG Health, 71% of leaders say they would consider partnering with a health system, up from 57% the year prior, while 10% of independent centers anticipate selling in 2026, nearly double last year’s figure.
The trend signals a growing shift toward scale and collaboration as a way to stabilize margins and manage rising costs.
Technology and service line expansion fuel targeted growth
At the same time, ASCs are investing in technology and service line expansion to capture new outpatient volume. Leaders point to growing adoption of AI in revenue cycle operations and continued investment in robotic surgery, particularly in orthopedic and spine procedures, as key trends shaping 2026.
These shifts are being reinforced by CMS policy changes, with nearly 300 procedures transitioning from the inpatient-only list to outpatient settings, a move expected to drive additional case volume and revenue growth in ASC-focused specialties.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
